A combined genetic score showed up to a 30% difference in HbA1c reduction be-tween low- and high-response carriers, highlighting the clinical relevance of these variants, though effects were specific to GLP-1 receptor agonists and not other drug classes
Prescription injectables like semaglutide (injectable) and tirzepatide (injectable) often produce larger average weight loss in human clinical trials but require clinical oversight
Your treatment plan will depend on your specific health needs, so always talk to your doctor before starting or changing any treatment
Teeth Problems Because youre likely eating and possibly also drinking less while on a GLP-1, your mouth produces less saliva than usual, says Oritz-Pujols
[DOI] [PubMed] [Google Scholar] Neumiller JJ, Campbell RK
GLP-1 manufacturers often require a formal ophthalmological examination in their clinical trials because there is a proven small risk that these drugs might cause worsening of diabetic retinopathy